Literature DB >> 19900496

Modified natural nanoparticles as contrast agents for medical imaging.

David P Cormode1, Peter A Jarzyna, Willem J M Mulder, Zahi A Fayad.   

Abstract

The development of novel and effective contrast agents is one of the drivers of the ongoing improvement in medical imaging. Many of the new agents reported are nanoparticle-based. There are a variety of natural nanoparticles known, e.g. lipoproteins, viruses or ferritin. Natural nanoparticles have advantages as delivery platforms such as biodegradability. In addition, our understanding of natural nanoparticles is quite advanced, allowing their adaptation as contrast agents. They can be labeled with small molecules or ions such as Gd(3+) to act as contrast agents for magnetic resonance imaging, (18)F to act as positron emission tomography contrast agents or fluorophores to act as contrast agents for fluorescence techniques. Additionally, inorganic nanoparticles such as iron oxide, gold nanoparticles or quantum dots can be incorporated to add further contrast functionality. Furthermore, these natural nanoparticle contrast agents can be re-routed from their natural targets via the attachment of targeting molecules. In this review, we discuss the various modified natural nanoparticles that have been exploited as contrast agents. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19900496      PMCID: PMC2827667          DOI: 10.1016/j.addr.2009.11.005

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  105 in total

1.  A virus-based single-enzyme nanoreactor.

Authors:  Marta Comellas-Aragonès; Hans Engelkamp; Victor I Claessen; Nico A J M Sommerdijk; Alan E Rowan; Peter C M Christianen; Jan C Maan; Benedictus J M Verduin; Jeroen J L M Cornelissen; Roeland J M Nolte
Journal:  Nat Nanotechnol       Date:  2007-09-23       Impact factor: 39.213

2.  Nondenaturing polyacrylamide gradient gel electrophoresis.

Authors:  A V Nichols; R M Krauss; T A Musliner
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

3.  Magnetic resonance visualization of tumor angiogenesis by targeting neural cell adhesion molecules with the highly sensitive gadolinium-loaded apoferritin probe.

Authors:  Simonetta Geninatti Crich; Benedetta Bussolati; Lorenzo Tei; Cristina Grange; Giovanna Esposito; Stefania Lanzardo; Giovanni Camussi; Silvio Aime
Journal:  Cancer Res       Date:  2006-09-15       Impact factor: 12.701

Review 4.  Hepatic MRI with SPIO: detection and characterization of focal liver lesions.

Authors:  P Reimer; B Tombach
Journal:  Eur Radiol       Date:  1998       Impact factor: 5.315

5.  Mimicking liver iron overload using liposomal ferritin preparations.

Authors:  John C Wood; Joe D Fassler; Tom Meade
Journal:  Magn Reson Med       Date:  2004-03       Impact factor: 4.668

6.  Viral capsids as MRI contrast agents.

Authors:  Lars Liepold; Stasia Anderson; Deborah Willits; Luke Oltrogge; Joseph A Frank; Trevor Douglas; Mark Young
Journal:  Magn Reson Med       Date:  2007-11       Impact factor: 4.668

7.  Encapsulation of platinum anticancer drugs by apoferritin.

Authors:  Zhen Yang; Xiaoyong Wang; Huajia Diao; Junfeng Zhang; Hongyan Li; Hongzhe Sun; Zijian Guo
Journal:  Chem Commun (Camb)       Date:  2007-05-17       Impact factor: 6.222

8.  Bio-distribution, toxicity and pathology of cowpea mosaic virus nanoparticles in vivo.

Authors:  Pratik Singh; Duane Prasuhn; Robert M Yeh; Giuseppe Destito; Chris S Rae; Kent Osborn; M G Finn; Marianne Manchester
Journal:  J Control Release       Date:  2007-04-13       Impact factor: 9.776

Review 9.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

Authors:  Morteza Naghavi; Peter Libby; Erling Falk; S Ward Casscells; Silvio Litovsky; John Rumberger; Juan Jose Badimon; Christodoulos Stefanadis; Pedro Moreno; Gerard Pasterkamp; Zahi Fayad; Peter H Stone; Sergio Waxman; Paolo Raggi; Mohammad Madjid; Alireza Zarrabi; Allen Burke; Chun Yuan; Peter J Fitzgerald; David S Siscovick; Chris L de Korte; Masanori Aikawa; K E Juhani Airaksinen; Gerd Assmann; Christoph R Becker; James H Chesebro; Andrew Farb; Zorina S Galis; Chris Jackson; Ik-Kyung Jang; Wolfgang Koenig; Robert A Lodder; Keith March; Jasenka Demirovic; Mohamad Navab; Silvia G Priori; Mark D Rekhter; Raymond Bahr; Scott M Grundy; Roxana Mehran; Antonio Colombo; Eric Boerwinkle; Christie Ballantyne; William Insull; Robert S Schwartz; Robert Vogel; Patrick W Serruys; Goran K Hansson; David P Faxon; Sanjay Kaul; Helmut Drexler; Philip Greenland; James E Muller; Renu Virmani; Paul M Ridker; Douglas P Zipes; Prediman K Shah; James T Willerson
Journal:  Circulation       Date:  2003-10-07       Impact factor: 29.690

10.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245

View more
  44 in total

1.  CuInSe/ZnS core/shell NIR quantum dots for biomedical imaging.

Authors:  Jeaho Park; Charlene Dvoracek; Kwan Hyi Lee; Justin F Galloway; Hyo-Eun C Bhang; Martin G Pomper; Peter C Searson
Journal:  Small       Date:  2011-09-21       Impact factor: 13.281

2.  MRI stem cell tracking for therapy in experimental cerebral ischemia.

Authors:  Pedro Ramos-Cabrer; Mathias Hoehn
Journal:  Transl Stroke Res       Date:  2011-10-27       Impact factor: 6.829

3.  Sortase-Mediated Ligation as a Modular Approach for the Covalent Attachment of Proteins to the Exterior of the Bacteriophage P22 Virus-like Particle.

Authors:  Dustin Patterson; Benjamin Schwarz; John Avera; Brian Western; Matthew Hicks; Paul Krugler; Matthew Terra; Masaki Uchida; Kimberly McCoy; Trevor Douglas
Journal:  Bioconjug Chem       Date:  2017-06-30       Impact factor: 4.774

4.  Disruptive chemical doping in a ferritin-based iron oxide nanoparticle to decrease r2 and enhance detection with T1-weighted MRI.

Authors:  M Veronica Clavijo Jordan; Scott C Beeman; Edwin J Baldelomar; Kevin M Bennett
Journal:  Contrast Media Mol Imaging       Date:  2014-04-25       Impact factor: 3.161

Review 5.  Nanodiscs in Membrane Biochemistry and Biophysics.

Authors:  Ilia G Denisov; Stephen G Sligar
Journal:  Chem Rev       Date:  2017-02-08       Impact factor: 60.622

Review 6.  Using Nanoparticles in Medicine for Liver Cancer Imaging.

Authors:  Farideh Farokhi Moghadam
Journal:  Oman Med J       Date:  2017-07

7.  Gadolinium-Based Contrast Agents for Vessel Wall Magnetic Resonance Imaging (MRI) of Atherosclerosis.

Authors:  Claudia Calcagno; Sarayu Ramachandran; Antoine Millon; Philip M Robson; Venkatesh Mani; Zahi Fayad
Journal:  Curr Cardiovasc Imaging Rep       Date:  2012-10-14

8.  Quantitative fluorescence tomography using a combined tri-modality FT/DOT/XCT system.

Authors:  Yuting Lin; William C Barber; Jan S Iwanczyk; Werner Roeck; Orhan Nalcioglu; Gultekin Gulsen
Journal:  Opt Express       Date:  2010-04-12       Impact factor: 3.894

Review 9.  Paramagnetic and fluorescent liposomes for target-specific imaging and therapy of tumor angiogenesis.

Authors:  Gustav J Strijkers; Ewelina Kluza; Geralda A F Van Tilborg; Daisy W J van der Schaft; Arjan W Griffioen; Willem J M Mulder; Klaas Nicolay
Journal:  Angiogenesis       Date:  2010-06       Impact factor: 9.596

Review 10.  Lipoproteins and lipoprotein mimetics for imaging and drug delivery.

Authors:  C Shad Thaxton; Jonathan S Rink; Pratap C Naha; David P Cormode
Journal:  Adv Drug Deliv Rev       Date:  2016-04-29       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.